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N-cadherin and integrin blockade inhibit arteriolar  
myogenic reactivity but not pressure-induced increases  
in intracellular Ca2+
Teresa Y. Jackson, Zhe Sun, Luis A. Martinez-Lemus, Michael A. Hill and Gerald A. Meininger*
Department of Medical Pharmacology and Physiology, Dalton Cardiovascular Research Center, University of Missouri, Columbia, MO, USA
The vascular myogenic response is characterized by arterial constriction in response to an 
increase in intraluminal pressure and dilatation to a decrease in pressure. This mechanism is 
important for the regulation of blood flow, capillary pressure, and arterial pressure. The identity 
of the mechanosensory mechanism(s) for this response is incompletely understood but has 
been shown to include the integrins as cell–extracellular matrix receptors. The possibility that 
a cell–cell adhesion receptor is involved has not been studied. Thus, we tested the hypothesis 
that N-cadherin, a cell–cell adhesion molecule in vascular smooth muscle cells (VSMCs), was 
important for myogenic responsiveness. The purpose of this study was to investigate: (1) 
whether cadherin inhibition blocks myogenic responses to increases in intraluminal pressure 
and (2) the effect of the cadherin or integrin blockade on pressure-induced changes in [Ca2+]i. 
Cadherin blockade was tested in isolated rat cremaster arterioles on myogenic responses to 
acute pressure steps from 60 to 100 mmHg and changes in VSMC Ca2+ were measured using 
fura-2. In the presence of a synthetic cadherin inhibitory peptide or a function-blocking antibody, 
myogenic responses were inhibited. In contrast, during N-cadherin blockade, pressure-induced 
changes in [Ca2+]i were not altered. Similarly, vessels treated with function-blocking β1- or 
β3-integrin antibodies maintained pressure-induced [Ca2+]i responses despite inhibition of 
myogenic constriction. Collectively, these data suggest that both cadherins and integrins play a 
fundamental role in mediating myogenic constriction but argue against their direct involvement 
in mediating pressure-induced [Ca2+]i increases.
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via activation of non-selective cation channels with subsequent 
voltage-gated Ca2+ entry leading to contraction of smooth mus-
cle cells (Harder, 1984; Davis et al., 1992a,b; Zou et al., 1995).
Thus, Ca2+ is generally perceived to play a pivotal and central 
role in the myogenic response. There are several reviews of 
this topic that provide a more detailed overview of possible 
cellular mechanisms contributing to the myogenic response 
(Johnson, 1977; Davis and Hill, 1999; Schubert and Mulvany, 
1999; Hill et al., 2006).
In comparison to the information available on the intracellular 
signals involved in myogenic contraction, the identity of the sensory 
elements that can detect changes in intraluminal pressure remains 
incomplete. Specifically, less emphasis has been placed on the role 
of cell adhesion proteins, cytoskeletal elements, and extracellular 
matrix (ECM) proteins. Previous research in our laboratory has 
shown that inhibition of αvβ3 and α5β1-integrins prevents myo-
genic responsiveness in cremaster arterioles (Martinez-Lemus et al., 
2005a) demonstrating the importance of a cell–ECM interaction. 
In addition to cell–matrix contacts the vascular wall contains a 
variety of cell–cell junctions (Hill et al., 2009) that have yet to 
be considered with respect to a role in myogenic responsiveness. 
Therefore, we considered the hypothesis that cell–cell adhesive 
interactions involving cadherins, a family of calcium-dependent 
IntroductIon
The myogenic response refers to the rapid vasomotor reaction of 
blood vessels to changes in intraluminal pressure. The vasomotor 
response is characterized by a blood vessel’s ability to constrict 
to an increase in intraluminal pressure and to dilate following a 
decrease in pressure. This mechanism, inherent to vascular smooth 
muscle, aids in the autoregulation of blood flow, arterial and capil-
lary pressure, and maintenance of peripheral vascular resistance. 
Importantly, myogenic constriction provides a level of tone upon 
which vasodilators can act to lower peripheral resistance. In addi-
tion to playing a role in local control of microvascular hemodynam-
ics, abnormalities in myogenic responsiveness have been associated 
with the vascular complications seen in hypertension and   diabetes 
(Meininger and Trzeciakowski, 1988; Hill and Meininger, 1993; 
Schofield et al., 2002).
A number of cellular processes and signals, including acti-
vation/deactivation of ion channels and kinases/phosphatases 
and changes in [Ca2+]i, have been implicated in myogenic con-
traction (Jaggar et al., 1998; Zou et al., 2000; Wesselman et al., 
2001; Cipolla et al., 2002; Bolz et al., 2003; Gokina et al., 2005).
Specifically, with respect to [Ca2+]i, an increase in wall tension or 
cell stretch (i.e., resulting from an increase in pressure) leads to 
vascular smooth muscle cell (VSMC) membrane depolarization 
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(476 μM) sequence-containing peptide LRAHAVDVNG (leucine–
arginine–alanine–histidine–alanine–valine–aspartic acid–valine–
asparagine–glycine-NH2) peptide (Bachem). The HGV-containing 
LRAHGVDVNG  (leucine–arginine–alanine–histidine–glycine–
valine–aspartic  acid–valine–asparagine–glycine-NH2)  peptide 
(476 μM; Bachem) was used similarly as an inactive control peptide. 
VSMC N-cadherin was also blocked with an inhibitory antibody, 
200 μg/ml anti-N-cadherin clone GC-4 (Sigma). Two hundred 
microgram per milliliter of the anti-VE-cadherin (Sigma) was 
used as a control antibody.
Vascular smooth muscle cell β1- or β3-integrins were blocked 
with the following antibodies: 50 μg/ml anti-β3-integrin function-
blocking antibody F11 or 50 μg/ml anti-β1-integrin antibody Ha2/5 
(Pharmingen) as previously described in detail (Martinez-Lemus 
et al., 2005a).
[ca2+]i and Vessel dIameter measurements
Changes in [Ca2+]i were measured following incubation of vessels 
with 2.0 μM Fura-2-acetoxymethyl ester (Fura-2-AM; Molecular 
Probes) for 60–90 min at room temperature in PSS (without albu-
min) containing 0.5% dimethyl sulfoxide (DMSO) and 0.01% 
Pluronic F-127. The dye loading procedure was followed by a 
30-min washout period with fresh, heated PSS (without albumin) 
solution. Details of this protocol have been previously published 
(Meininger et al., 1991).
experImental protocols
effect of n-cadherIn InhIbItIon on myogenIc responsIVeness
Arterioles  (60  mmHg  intraluminal  pressure)  were  warmed  to 
34.5°C for 1 h and allowed to develop spontaneous myogenic 
tone. A control series of step increments in intraluminal pressure 
(60–100, 20 mmHg increments) was performed at 5 min intervals. 
Diameter was recorded by a video microscopy system. After the ini-
tial series of pressure steps, the vessel was returned to 60 mmHg for 
15 min. The arteriole was then incubated with either the N-cadherin 
antibody or peptide for 15 min. Next, a second series of pressure 
steps were performed in the continued presence of the antibody or 
peptide. The vessel was then returned to a pressure of 60 mmHg 
and washed with fresh PSS without the antibody or peptide for 
15 min. At the completion of the blocking protocol, the arteriole was 
dilated with 100 μM adenosine and then followed by calcium-free 
PSS containing 100 μM adenosine to acquire the maximum passive 
diameter. Details of this protocol have been published previously 
(Martinez-Lemus et al., 2005a). Appropriate time controls were 
conducted to ensure reproducibility of the myogenic responses 
across the period of the study.
[ca2+]i measurements durIng IntralumInal Increases  
In pressure
After vessels were incubated with the Ca2+ indicator, fura-2, the 
response to a step increment (60–100 mmHg) in intraluminal 
pressure was examined. The intraluminal pressure was returned to 
60 mmHg for 10 min after which antibody or peptide was applied 
for 10 min. Intraluminal pressure was then increased from 60 to 
100 mmHg for 5 min and changes in [Ca2+]i and diameter recorded. 
Intraluminal pressure was returned to 60 mmHg for 10 min followed 
by exposure of the vessel to 10 μM norepinephrine (in the   presence 
transmembrane adhesion proteins, contribute to the mechanosen-
sory pathway(s) that “sense” force and coordinate signaling between 
smooth muscle cells.
To test the hypothesis that cadherins are an important com-
ponent  in  the  myogenic  response,  intraluminal  pressure  was 
increased in cremaster arterioles in the absence and presence of 
an inhibitory antibody known to bind selectively N-cadherin or 
a cadherin inhibitory peptide (histidine–alanine–valine, HAV). 
N-cadherin was selected for investigation because previous reports 
have identified it as the prominent VSMC cadherin (Moiseeva, 
2001). Additional studies, using the calcium-sensitive dye fura-2, 
examined whether cadherin and/or integrin signaling lie upstream 
of changes in [Ca2+]i.
materIals and methods
anImal handlIng
All experimental procedures were approved by the University of 
Missouri-Columbia Institutional Animal Care and Use Committee. 
Male Sprague-Dawley rats (Harlan, Indianapolis, IN, USA) weighing 
200–300 g were used in this study. The animals were anesthetized with 
an intraperitoneal injection of pentobarbital sodium (100 mg/Kg).
Vessel IsolatIon
After reaching a surgical level of anesthesia, the cremaster muscle 
was excised and pinned flat in a refrigerated (4°C) dissecting 
chamber containing a physiological saline solution (PSS) of the 
composition (in mM): 145.0 NaCl, 4.7 KCl, 2.0 CaCl2, 1.2 MgSO4, 
1.0 NaH2PO4, 5.0 d-glucose, 3.0 MOPS buffer, 2.0 pyruvate, 0.02 
EDTA, and 0.15 BSA, pH 7.4. First-order feed arterioles were iso-
lated from the muscle, cannulated in the absence of flow using two 
glass micropipettes, and pressurized to 60 mmHg as previously 
described (Falcone et al., 1991). Vessel preparations were super-
fused with a PSS (without albumin) as described in previous pub-
lications (Falcone et al., 1991; Meininger et al., 1991). The arteriole 
lumen diameter was recorded online using a video microscopy 
system and a calibrated video dimension analysis device.
Immunofluorescent labelIng of Vsmcs
As  an  approach  for  immunohistochemical  identification  of 
N-cadherin, VSMCs were isolated from cremaster arterioles as 
previously described (Wu et al., 1998). Cells were allowed to grow 
until 50% confluent on glass-bottom tissue culture dishes, washed 
with DPBS, and fixed with 2% paraformaldehyde. After washing, 
glycine buffer (0.1 mM glycine) was added to quench any remain-
ing paraformaldehyde. Subsequently, cells were incubated with a 
monoclonal N-cadherin primary antibody (clone GC-4; Sigma) at 
4°C overnight. Cells were then washed six times with cold buffer 
(composed of 150 mM NaCl, 15 mM Na3C6H5O7, and 0.05% Triton 
X-100), followed by incubation with Alexa Fluor 488-conjugated 
secondary antibody (for 1 h at room temperature in a dark envi-
ronment). Labeled cells were washed six times with cold buffer and 
imaged on a confocal microscope.
antIbody and peptIde treatment
All antibodies and peptides were diluted in PSS and added ablu-
minally to the cannulated arterioles in the superfusion solution. 
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N-cadherin antibody (GC-4) was applied to the vessel and the effect 
of the treatment evaluated during a second series of pressure steps. 
In these experiments, the slope of the initial pressure–diameter 
response was −0.3 ± 0.04 which was significantly (p < 0.05) different 
to that after treatment with the antibody (slope not significantly 
different from 0) indicating inhibition of myogenic vasoconstric-
tion (n = 6; Figures 3A,B). In contrast, treatment of the arteri-
oles with an anti-VE-cadherin antibody, as a control, showed no 
significant change in myogenic responsiveness between the two 
series of pressure steps (−0.2 ± 0.05 compared to −0.2 ± 0.02, n = 4; 
Figures 3C,D).
In a second set of experiments, arterioles were treated with the 
synthetic inhibitory peptide, HAV, which inhibited the myogenic 
response. The slope of the response to the baseline pressure step was 
−0.2 ± 0.02 whereas the slope was not significantly different from 
0 after treatment with the peptide (n = 6; Figures 4A,B). Vessels 
treated with a non-inhibitory control HGV-containing peptide did 
not show a significant change in myogenic responsiveness (slope 
−0.3 ± 0.03 compared to −0.2 ± 0.04, n = 6; Figures 4C,D).After 
exposure to either the anti-N-cadherin or HAV peptide, the arte-
rioles continued to exhibit basal tone as resting diameters were not 
significantly altered, however the vessel myogenic response was 
abolished by both treatments (Figures 3A and 4A).
of the antibody or peptide). Maximum diameter was measured 
following superfusion with calcium-free PSS containing 100 μM 
adenosine as above (Falcone et al., 1991; Meininger et al., 1991).
data analysIs and statIstIcs
Diameter changes are presented as percentage of control, where con-
trol represents the pre-pressure step diameter value at 60 mmHg. 
The slope of the myogenic pressure–diameter relationship as deter-
mined by regression analysis was used as an index of myogenic gain. 
Thus, a negative slope of the myogenic pressure–diameter relation-
ship represents myogenic vasoconstriction (i.e., the arterioles ability 
to reduce its diameter in response to an increase in intraluminal 
pressure). Analyses of slopes and calcium changes were performed 
using paired Student t-tests. All data are expressed as mean ± SEM. 
In all analyses, p < 0.05 represents the level of significance.
results
presence of n-cadherIn In Vsmcs
To demonstrate the presence of N-cadherin in arteriolar VSMC, 
immunofluorescence microscopy was performed on cultured arte-
riolar VSMCs. As shown in Figure 1, N-cadherin was observed in 
individual VSMCs. N-cadherin was found localized to cell edges and 
particularly in areas of overlapping cell contact. This demonstrates 
the presence of N-cadherin and provides support for the hypothesis 
of possible involvement of this protein in myogenic behavior.
myogenIc response durIng n-cadherIn InhIbItIon Is abolIshed
Initial control experiments established that myogenic vasoconstric-
tor responses were reproducible over the time course required to 
conduct the protocols (Figures 2A,B). Group data showed that 
the slope of the pressure–diameter response (an index of myo-
genic reactivity) of an initial series of pressure steps (60 to 80 to 
100 mmHg) to be −0.3 ± 0.1 and not statistically different compared 
to −0.3 ± 0.1 for a second control set of pressure steps performed 
under identical conditions and in the absence of peptide or anti-
body treatment (n = 5; Figure 2B).
To test whether N-cadherin inhibition would affect myogenic 
responsiveness, we performed two sets of experiments. Following 
measurement  of  a  baseline  response  to  pressure,  inhibitory 
Figure 1 | Fluorescent images of cultured VSMCs fluorescently 
immunolabeled with N-cadherin (green). N-cadherin was distributed along 
cell edges (arrows in left panel) and in areas of cell–cell overlap between 
adjacent cells (dashed circle in right panel).
Figure 2 | Myogenic responsiveness exhibited in isolated cremaster 
arterioles. Slope of myogenic pressure–diameter relationship as determined 
by regression analyses used as an index of myogenic gain. (A) Percentage 
control diameter of isolated arterioles exposed to increments in intraluminal 
pressure (time control-no drug treatment). (B) Slope before and after step 
increments in pressure for the two separate control series (n = 5). Data are 
presented as mean ± SEM.Frontiers in Physiology  |  Vascular Physiology    December 2010  | Volume 1  | Article 165  |  4
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antibody, myogenic vasoconstriction was attenuated (percentage 
change in diameter −6.4 ± 1.3% compared to −1.2 ± 2.3%, p < 0.05) 
when intraluminal pressure was increased from 60 to 100 mmHg 
(n = 6; Figures 8A,B). However, the pressure-induced change in 
[Ca2+]i was unaffected; 5.6 ± 1.1% compared to 6.5 ± 1.2%. Similar 
observations were seen during exposure to the anti β3-integrin anti-
body (n = 5; Figures 8C,D). Thus, there was a significant inhibition 
in the diameter response (−8.2 ± 2.0% compared to −3.6 ± 1.2%, 
p < 0.05) while changes in [Ca2+]i responses were not significantly 
altered (5.8 ± 1.0% compared to 4.3 ± 0.5%).
dIscussIon
The signaling cascade underlying the arteriolar myogenic response 
is initiated when an intraluminal pressure stimulus activates VSMC. 
Key in this process is the ability of mechanosensors to detect changes 
in forces acting on the vessel wall leading to VSMC activation and 
subsequent vasomotor responses. Complete knowledge of the cellu-
lar events involved in this mechanism is unknown. We investigated 
the hypothesis that cadherins and downstream associated Ca2+ sign-
aling events are involved in the myogenic response. Consistent with 
this hypothesis, the data from the present study show that inhibi-
tion of N-cadherin attenuates myogenic vasoconstriction however, 
inhibition occurs without altering pressure-induced increases in 
[Ca2+]i suggesting that it is not a downstream associated signal.
cadherIn or IntegrIn blockade InhIbIts myogenIc response 
whIle not affectIng [ca2+]i
Changes in diameter and [Ca2+]i were simultaneously measured and 
compared before and after (following 5 min and reaching a steady 
state value) a step change in intravascular pressure (60–100 mmHg). 
Time controls showed no significant changes in [Ca2+]i or diameter 
(n = 6; Figure 5). During N-cadherin blockade, myogenic vasocon-
striction was significantly reduced when treated with HAV peptide; 
however, changes in [Ca2+]i were not significantly altered. The first 
step increase in pressure caused a 11.7 ± 5.8% change in [Ca2+]i and 
−9.1 ± 2.6% in diameter while the second step increase in pressure 
exhibited a 6.8 ± 1.3% change in [Ca2+]i and 0.5 ± 0.6% in diam-
eter (n = 9; Figures 6A,B). There were no significant changes in 
[Ca2+]i or diameter of the arterioles treated with the control HGV 
peptide (n = 7; Figures 6C,D). Arterioles treated with the inhibi-
tory N-cadherin antibody showed a decrease in pressure-induced 
myogenic response (percentage of change in diameter −5.0 ± 1.8% 
compared to −0.9 ± 2.4%) but still showed an increase in [Ca2+]i 
(17.0 ± 6.7% compared to 11.3 ± 3.9%; n = 4; Figures 7A,B).
For comparison, we investigated Ca2+ responses in arterioles 
in which the β1- or β3-integrins were inhibited. Previous pub-
lished work from our laboratory has shown that inhibition of these 
integrins blocks myogenic responsiveness (Martinez-Lemus et al., 
2005a). During blockade ofβ1-integrin with a function-blocking 
Figure 3 | Anti-N-cadherin treatment inhibited pressure-induced 
myogenic vasoconstriction. The reduced slope of myogenic pressure–
diameter relationship (i.e., index of myogenic gain) as determined by regression 
analyses demonstrates the ability of anti-N-Cadherin treatment to inhibit the 
myogenic response. (A) Percentage control diameter of isolated arterioles 
exposed to increments in intraluminal pressure before and after the anti-N-
Cadherin antibody treatment. (B) Slope of the pressure–diameter regression line 
before the addition of the antibody and while in the presence of the inhibitory 
antibody (n = 6). (C) Percentage control diameter of isolated arterioles exposed 
to increments in intraluminal pressure before and after addition of the 
anti-VE-Cadherin antibody treatment as a control. (D) Before the addition of the 
antibody and while in the presence of the abluminal control antibody (n = 4). 
Data are presented as mean ± SEM. *Significantly different (p < 0.05) from 
control (first series of step increments in pressure in the same vessel).www.frontiersin.org  December 2010  | Volume 1  | Article 165  |  5
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Cadherins are a superfamily of calcium-dependent, trans-
membrane cell–cell adhesion proteins that form adherens junc-
tions. The cadherins have been reported to play a major role 
in embryogenesis, tissue morphogenesis, and other biological 
processes  (Takeichi,  1991;  George  and  Beeching,  2006).  The 
cadherin superfamily includes classical cadherins, desmosomal 
cadherins, and proto cadherins (Leckband and Prakasam, 2006). 
The classical cadherins have been studied in more detail than the 
other subfamilies of cadherins. Classical cadherins are glycopro-
teins that are composed of an ectodomain containing calcium 
binding sites, transmembrane domain, and intercellular domain 
(Troyanovsky, 1999). It is widely recognized that cell–cell/cad-
herin to cadherin adhesion is mediated by a highly conserved 
tripeptide, HAV, located in the ectodomain (Noe et al., 1999). 
The intercellular domain binds to the cytoskeleton by interact-
ing with scaffolding proteins known as catenins (Aberle et al., 
1996). The cytoplasmic tail of the cadherin binds directly to 
β- or γ-catenin, which permits the binding of α-catenin to β- 
or γ-catenin. The cadherin–catenin complex therefore links the 
cadherin to the actin cytoskeleton. Thus, cadherins provide a 
potential pathway for connection of the intercellular junctions 
and intracellular environment that may contribute to mechan-
otransduction. Importantly, in regard to myogenic vasoconstric-
tion, evidence has been presented previously for involvement 
of the actin cytoskeleton (Cipolla et al., 2002; Gokina and Osol, 
2002). In the context of the present study it is important to 
consider that an acute action of pressure on cadherins is being 
considered. In situations of prolonged exposure to increased 
Figure 4 | Histidine–alanine–valine peptide inhibited pressure-induced 
myogenic vasoconstriction. The reduced slope of myogenic pressure–
diameter relationship (i.e., index of myogenic gain) as determined by regression 
analyses demonstrates the ability of HAV peptide to inhibit the myogenic 
response. (A) Percentage control diameter of isolated arterioles exposed to 
increments in intraluminal pressure before and after addition of the HAV peptide 
treatment. (B) Slope of the pressure–diameter regression line before the 
addition of the antibody and while in the presence of the abluminal inhibitory 
peptide (n = 6). (C) Percentage control diameter of isolated arterioles exposed to 
increments in intraluminal pressure before and after the control anti-VE-Cadherin 
antibody treatment. (D) Slope of the pressure–diameter regression line before 
the addition of the peptide and while in the presence of the abluminal control 
peptide (n = 6). Data are presented as mean ± SEM. *Significantly different from 
the first series of step increments in pressure in the same vessel.
Figure 5 | Myogenic response exhibited in following a step change in 
intravascular pressure from 60 to 100 mmHg in isolated cremaster 
arterioles. [Ca2+]i was measured in these arterioles using fura-2 to estimate 
VSMC Ca2+ changes in the vessel wall. (A) Percentage of [Ca2+]i change in 
arterioles exposed to increases in intraluminal pressure. (B) Percentage of 
change in diameter before and after repeated step increase in pressure as a 
time control (n = 6). Data are presented as mean ± SEM.Frontiers in Physiology  |  Vascular Physiology    December 2010  | Volume 1  | Article 165  |  6
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pressure (for example in hypertension and vascular remodeling) 
it is conceivable that regulation of cadherins may occur at the 
expression level.
Investigative  studies  focusing  on  the  function  of  cadherins 
in  vasomotor  regulation  are  limited.  Studies  have  shown  that 
N-cadherin is normally present in the rat vasculature and provides 
cell–cell contact between VSMCs (Jones et al., 2002). Using immun-
ofluorescence, our study also shows the presence of N-cadherin 
in cultured arteriolar VSMCs. Further, as most investigations of 
cadherins in VSMC have focused on migration, proliferation, apop-
tosis, and survival (for example as relates to restenosis) the cur-
rent study is the first to show a direct role of N-cadherin in acute 
vasomotor responses.
Increasing attention has been focused on a mechanosensory 
mechanism to explain myogenic phenomena (Davis and Hill, 
1999; Schubert and Mulvany, 1999; Hill et al., 2009). Recent evi-
dence has supported the hypothesis that an extracellular matrix–
integrin pathway is important (Martinez-Lemus et al., 2005b). 
Consistent with this the present study provides further support 
for the involvement of β1- and β3-integrins while extending 
this concept to include a role for an additional junctional com-
plex, namely N-cadherin. Paradoxically, while blockade of both 
pathways inhibits myogenic responsiveness, pressure-induced 
increases in [Ca2+]i persisted. One possibility is that cadherins 
and integrins are more strongly linked to events controlling 
Ca2+ sensitivity rather than Ca2+ entry. In this regard, calcium 
sensitization has been suggested to be involved in the myogenic 
Figure 6 | The N-cadherin binding inhibitory peptide, HAV, inhibited 
pressure-induced myogenic vasoconstriction but not [Ca2+]i changes 
in the vessel wall. (A) Percentage of [Ca2+]i change in arterioles exposed 
to an increase in intraluminal pressure before and after HAV peptide 
treatment. (B) Percentage of change in diameter before and after treatment 
with the HAV inhibitory peptide (n = 9). (C) Percentage of [Ca2+]i change in 
arterioles exposed to an increase in intraluminal pressure before and 
after HGV (control) peptide treatment. (D) Percentage of change in diameter 
before and after treatment with the HGV control peptide (n = 7). Data are 
presented as mean ± SEM. *Significantly different from before peptide 
treatment (first series of step increments in pressure in the  
same vessel).
Figure 7 | Anti-N-cadherin decreased pressure-induced myogenic 
vasoconstriction without a significant effect on [Ca2+]i increase in the 
vessel wall. (A) Percentage of [Ca2+]i change in arterioles exposed to an 
increase in intraluminal pressure before and after anti-N-cadherin treatment. 
(B) Percentage of change in diameter before and after treatment with the 
inhibitory antibody (n = 4). Data are presented as mean ± SEM.www.frontiersin.org  December 2010  | Volume 1  | Article 165  |  7
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cytoskeleton-based mechanism (Brunton et al., 2004; Leckband 
and Prakasam, 2006; Mege et al., 2006). Cytoskeletal coopera-
tion has been demonstrated through the interaction of actin 
filaments, intermediate filaments, and microtubules to pro-
vide integration of mechanical and cell signaling events (Noe 
et al., 1999; Ingber, 2006; Ren et al., 2009). In cancer models, 
for example, studies have suggested that there is a cadherin–
integrin crosstalk that is important for tumor cell invasion 
and cell migration (Avizienyte et al., 2002; Zhang et al., 2006). 
Therefore, there may be a similar crosstalk between these two 
proteins in pressure-induced vasoconstriction.
In  conclusion,  these  studies  provide  the  first  evidence  for 
involvement of the cadherins in regulation of arteriolar con-
traction. These results further support the hypothesis that both 
integrins and cadherins play a role in myogenic vasoconstric-
tion. The exact sensory mechanism of these proteins continues 
to require elucidation; however, the results suggest they may not 
function through a mechanism involving VSMC Ca2+ increase. 
Further investigation into the links between the Ca2+ sensitization 
and the actin polymerization pathway and integrin and cadherin 
signaling in the myogenic response is necessary. Delineation of 
these mechanisms may provide the rationale for the development 
of new therapeutic approaches in the treatment of vascular disease 
(Hill et al., 2009).
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response (Schubert et al., 2008; Johnson et al., 2009). The activa-
tion of protein kinase C (PKC) and Rho kinase have been shown 
to regulate Ca2+ sensitization (Hill et al., 1990,1996; Meininger 
et al., 1991; Narayanan et al., 1994) and lead to an increase in phos-
phorylated myosin light chain (MLC), which results in VSMC 
contraction that is independent of [Ca2+]i concentrations (Hill 
et al., 1996). Actin polymerization (Gokina and Osol, 2002) has 
also been suggested to play a significant role in the arteriolar 
myogenic response, and lies downstream of cadherin activation. 
Further, earlier studies from our laboratories (Meininger et al., 
1991; D’Angelo et al., 1997; Zou et al., 2000) and others (Schubert 
and Mulvany, 1999; Wesselman et al., 2001; Schubert et al., 2008) 
have shown that pressure induces relatively (as compared to an 
agonist) small changes in [Ca2+]i such that a change in sensitivity 
or actin polymerization could explain the paradoxical finding 
of inhibition of contraction despite a rise in [Ca2+]i. Due to the 
force and/or tension being placed on cadherins and integrins 
during pressure-induced stretch, these proteins may mechani-
cally activate the mentioned protein-kinase pathways and actin 
remodeling processes resulting in vessel constriction.
Involvement of integrins and cadherins in myogenic vaso-
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myogenic without affecting [Ca2+]i increases in response to pressure. 
(A) Percentage of [Ca2+]i change in arterioles exposed to an increase in 
intraluminal pressure before and after anti-β1-integrin. (B) Percentage of 
change in diameter before and after treatment with the inhibitory 
antibody (n = 6). (C) Percentage of [Ca2+]i change in arterioles exposed to 
an increase in intraluminal pressure before and after anti-β3-Integrin. 
(D) Percentage of change in diameter before and after treatment 
with the inhibitory antibody (n = 5). Data are presented as 
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